Literature DB >> 33796514

Cancer-Associated Retinopathy due to Clear Cell Renal Carcinoma.

Sushant Wagley1, Tu M Tran1, Paul W Mallory1, Michael S Lee1, Karen R Armbrust2, Bruce Trautman3, Sandra R Montezuma1.   

Abstract

An 84-year-old female presented with bilateral scotomas and progressive nyctalopia over 1 year. Best-corrected visual acuity was 20/50 in both eyes with reduced color vision. Goldmann visual field showed bilateral cecocentral scotomas and generalized constriction of the visual fields. This led to an electroretinogram showing an electronegative pattern consistent with autoimmune retinopathies. Infectious workup was negative. Anti-retinal antibodies were positive, leading to a presumed diagnosis of cancer-associated retinopathy (CAR). Imaging showed a previously unknown left renal lower pole mass, and she underwent a radical nephrectomy. Biopsy showed nuclear grade-3 clear cell renal carcinoma staged T1. The patient was treated with oral prednisone with no ocular improvement. We report on a rare case of clear cell renal carcinoma causing CAR. CAR is an important paraneoplastic syndrome to diagnose since the majority of ocular cases precede other manifestations of malignancy. Therefore, a timely diagnosis of CAR can be lifesaving or at least life-extending.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Autoimmune retinopathy; Cancer-associated retinopathy; Goldmann visual field; Paraneoplastic syndrome; Renal carcinoma

Year:  2020        PMID: 33796514      PMCID: PMC7989776          DOI: 10.1159/000511189

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  12 in total

1.  Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.

Authors:  Grazyna Adamus; Rachel Champaigne; Sufang Yang
Journal:  Clin Immunol       Date:  2019-11-23       Impact factor: 3.969

Review 2.  Immunopathogenesis of ophthalmological paraneoplastic syndromes: Recent findings.

Authors:  Monika Kordyś; Joanna Przeździecka-Dołyk; Anna Turno-Kręcicka; Marta Misiuk-Hojło
Journal:  Adv Clin Exp Med       Date:  2018-10       Impact factor: 1.727

3.  Clinical and immunological characterization of paraneoplastic retinopathy.

Authors:  Yukiko Makiyama; Takanobu Kikuchi; Atsushi Otani; Akio Oishi; Congrong Guo; Satoko Nakagawa; Ken Ogino; Hiroshi Kojima; Masafumi Kurimoto; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

Review 4.  Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.

Authors:  Ehsan Rahimy; David Sarraf
Journal:  Surv Ophthalmol       Date:  2013 Sep-Oct       Impact factor: 6.048

5.  Management and monitoring of cancer-associated retinopathy.

Authors:  J L Keltner; C E Thirkill; N K Tyler; A M Roth
Journal:  Arch Ophthalmol       Date:  1992-01

6.  Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy.

Authors:  Nancy Huynh; Yevgeniy Shildkrot; Ann-Marie Lobo; Lucia Sobrin
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-03-14

7.  Successful treatment of cancer-associated retinopathy with alemtuzumab.

Authors:  Ladan Espandar; Susan O'Brien; Charles Thirkill; Linda A Lubecki; Bita Esmaeli
Journal:  J Neurooncol       Date:  2007-01-25       Impact factor: 4.506

8.  GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy.

Authors:  Sufang Yang; Alexander Dizhoor; David J Wilson; Grazyna Adamus
Journal:  Transl Vis Sci Technol       Date:  2016-05-02       Impact factor: 3.283

9.  Cancer-associated retinopathy preceding the diagnosis of cancer.

Authors:  Florence Hoogewoud; Pauline Butori; Philippe Blanche; Antoine P Brézin
Journal:  BMC Ophthalmol       Date:  2018-11-03       Impact factor: 2.209

10.  Autoimmune retinopathy and optic neuropathy associated with enolase-positive renal oncocytoma.

Authors:  Justine L Cheng; Johanna D Beebe; Kenneth G Nepple; Yousef Zakharia; Robert F Mullins; Miles J Flamme-Wiese; Matthew J Thurtell; Ian C Han
Journal:  Am J Ophthalmol Case Rep       Date:  2018-09-10
View more
  1 in total

Review 1.  Paraneoplastic syndrome in neuroophthalmology.

Authors:  Longdan Kang; Chao Wan
Journal:  J Neurol       Date:  2022-07-02       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.